Global and United States Chronic Fatigue Syndrome Treatment Market Report & Forecast 2022-2028

Chronic fatigue syndrome, also known as Myalgic encephalomyelitis, is a chronic disease which lasts for six months and affects the central nervous system and the immune system. The disease leads to musculoskeletal disorders, impairment of long term memory, and disturbed sleep patterns. This results in substantial decline in social, occupational, educational, and personal activity among patients. There are no specific biomarkers or tests to diagnose chronic fatigue syndrome. Symptoms include sore throat, muscle pain, headache, and fatigue, which continues for months or years.
Market Analysis and Insights: Global and United States Chronic Fatigue Syndrome Treatment Market
This report focuses on global and United States Chronic Fatigue Syndrome Treatment market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Chronic Fatigue Syndrome Treatment market size is estimated to be worth US$ 282.4 million in 2022 and is forecast to a readjusted size of US$ 369.9 million by 2028 with a CAGR of 4.6% during the review period. Fully considering the economic change by this health crisis, by Type, Pain Relievers and NSAIDs accounting for % of the Chronic Fatigue Syndrome Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Distribution Channel, Hospital was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
Global Chronic Fatigue Syndrome Treatment key players include Pfizer, Mylan, Teva, Depomed, etc. Global top four manufacturers hold a share over 35%.
North America is the largest market, with a share about 50%, followed by Europe, and Asia-Pacific, both have a share over 45 percent.
In terms of product, Pain Relievers and NSAIDs is the largest segment, with a share over 60%. And in terms of application, the largest application is Retail Pharmacy, followed by Hospital.
Global Chronic Fatigue Syndrome Treatment Scope and Market Size
Chronic Fatigue Syndrome Treatment market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Chronic Fatigue Syndrome Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Chronic Fatigue Syndrome Treatment market size by players, by Type and by Distribution Channel, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Pain Relievers and NSAIDs
Antidepressant and Antipsychotic Drugs
Antimicrobial and Immunomodulatory Drugs
Segment by Distribution Channel
Hospital
Retail Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Pfizer
Teva
Mylan
Depomed
Mallinckrodt Pharmaceuticals
Eli Lilly
Bayer
Novartis
Sun Pharmaceutical
Astrazeneca
Lundbeck
Arbor Pharma